These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17507447)

  • 1. Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia.
    Bohnen NI; Kaufer DI; Hendrickson R; Constantine GM; Mathis CA; Moore RY
    J Neurol Neurosurg Psychiatry; 2007 Jun; 78(6):641-3. PubMed ID: 17507447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.
    Bohnen NI; Kaufer DI; Hendrickson R; Ivanco LS; Lopresti BJ; Constantine GM; Mathis ChA; Davis JG; Moore RY; Dekosky ST
    J Neurol; 2006 Feb; 253(2):242-7. PubMed ID: 16133720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.
    Bohnen NI; Kaufer DI; Ivanco LS; Lopresti B; Koeppe RA; Davis JG; Mathis CA; Moore RY; DeKosky ST
    Arch Neurol; 2003 Dec; 60(12):1745-8. PubMed ID: 14676050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia.
    Marshall GA; Shchelchkov E; Kaufer DI; Ivanco LS; Bohnen NI
    Acta Neurol Scand; 2006 Feb; 113(2):87-91. PubMed ID: 16411968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait speed in Parkinson disease correlates with cholinergic degeneration.
    Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Müller ML
    Neurology; 2013 Oct; 81(18):1611-6. PubMed ID: 24078735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
    Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MA; Albin RL; Frey KA
    Brain; 2010 Jun; 133(Pt 6):1747-54. PubMed ID: 20413575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of falls in Parkinson disease is associated with reduced cholinergic activity.
    Bohnen NI; Müller ML; Koeppe RA; Studenski SA; Kilbourn MA; Frey KA; Albin RL
    Neurology; 2009 Nov; 73(20):1670-6. PubMed ID: 19917989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
    Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MR; Gilman S; Albin RL; Frey KA
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1609-17. PubMed ID: 22569194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.
    Kotagal V; Albin RL; Müller ML; Koeppe RA; Chervin RD; Frey KA; Bohnen NI
    Ann Neurol; 2012 Apr; 71(4):560-8. PubMed ID: 22522445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
    Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI
    Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
    Bohnen NI; Kotagal V; Müller ML; Koeppe RA; Scott PJ; Albin RL; Frey KA; Petrou M
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1394-8. PubMed ID: 25454317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.
    Weathers SP; Kotagal V; Bohnen NI; Chou KL
    Parkinsonism Relat Disord; 2014 Jan; 20(1):13-6. PubMed ID: 24070538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders.
    Kotagal V; Müller ML; Kaufer DI; Koeppe RA; Bohnen NI
    Neurosci Lett; 2012 Apr; 514(2):169-72. PubMed ID: 22414859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic deficit and response to donepezil therapy in Parkinson's disease with dementia.
    Hiraoka K; Okamura N; Funaki Y; Hayashi A; Tashiro M; Hisanaga K; Fujii T; Takeda A; Yanai K; Iwata R; Mori E
    Eur Neurol; 2012; 68(3):137-43. PubMed ID: 22832236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.
    van der Zee S; Müller MLTM; Kanel P; van Laar T; Bohnen NI
    Mov Disord; 2021 Mar; 36(3):642-650. PubMed ID: 33137238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.
    Shimada H; Hirano S; Shinotoh H; Aotsuka A; Sato K; Tanaka N; Ota T; Asahina M; Fukushi K; Kuwabara S; Hattori T; Suhara T; Irie T
    Neurology; 2009 Jul; 73(4):273-8. PubMed ID: 19474411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.
    Hilker R; Thomas AV; Klein JC; Weisenbach S; Kalbe E; Burghaus L; Jacobs AH; Herholz K; Heiss WD
    Neurology; 2005 Dec; 65(11):1716-22. PubMed ID: 16344512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short latency afferent inhibition in Parkinson's disease patients with dementia.
    Celebi O; Temuçin CM; Elibol B; Saka E
    Mov Disord; 2012 Jul; 27(8):1052-5. PubMed ID: 22605543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.
    Baba T; Kikuchi A; Hirayama K; Nishio Y; Hosokai Y; Kanno S; Hasegawa T; Sugeno N; Konno M; Suzuki K; Takahashi S; Fukuda H; Aoki M; Itoyama Y; Mori E; Takeda A
    Brain; 2012 Jan; 135(Pt 1):161-9. PubMed ID: 22287381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy.
    Shinotoh H; Namba H; Yamaguchi M; Fukushi K; Nagatsuka S; Iyo M; Asahina M; Hattori T; Tanada S; Irie T
    Ann Neurol; 1999 Jul; 46(1):62-9. PubMed ID: 10401781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.